PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Habegger, K.M.* ; Stemmer, K. ; Cheng, C.* ; Müller, T.D. ; Heppner, K.M.* ; Ottaway, N.* ; Holland, J.* ; Hembree, J.L.* ; Smiley, D.* ; Gelfanov, V.* ; Krishna, R.* ; Arafat, A.M.* ; Konkar, A.* ; Belli, S.* ; Kapps, M.* ; Woods, S.C.* ; Hofmann, S.M. ; D'Alessio, D.* ; Pfluger, P.T. ; Perez-Tilve, D.* ; Seeley, R.J.* ; Konishi, M.* ; Itoh, N.* ; Kharitonenkov, A.* ; Spranger, J.* ; DiMarchi, R.D.* ; Tschöp, M.H.

Fibroblast growth factor 21 mediates specific glucagon actions.

Diabetes 62, 1453-1463 (2013)
Verlagsversion Volltext DOI PMC
Closed
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Glucagon, an essential regulator of glucose homeostasis, also modulates lipid metabolism and promotes weight loss, as reflected by the wasting observed in glucagonoma patients. Recently, coagonist peptides that include glucagon agonism have emerged as promising therapeutic candidates for the treatment of obesity and diabetes. We developed a novel stable and soluble glucagon receptor (GcgR) agonist, which allowed for in vivo dissection of glucagon action. As expected, chronic GcgR agonism in mice resulted in hyperglycemia and lower body fat and plasma cholesterol. Notably, GcgR activation also raised hepatic expression and circulating levels of fibroblast growth factor 21 (FGF21). This effect was retained in isolated primary hepatocytes from wild-type (WT) mice, but not GcgR knockout mice. We confirmed this link in healthy human volunteers, where injection of natural glucagon increased plasma FGF21 within hours. Functional relevance was evidenced in mice with genetic deletion of FGF21, where GcgR activation failed to induce the body weight loss and lipid metabolism changes observed in WT mice. Taken together, these data reveal for the first time that glucagon controls glucose, energy, and lipid metabolism at least in part via FGF21-dependent pathways.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
7.895
2.093
148
165
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Increases Energy-expenditure ; Ppar-alpha ; Insulin Sensitivity ; Body-weight ; Metabolism ; Mice ; Fgf21 ; Fibroblast-growth-factor-21 ; Pharmacology ; Degradation
Sprache englisch
Veröffentlichungsjahr 2013
HGF-Berichtsjahr 2013
ISSN (print) / ISBN 0012-1797
e-ISSN 1939-327X
Zeitschrift Diabetes
Quellenangaben Band: 62, Heft: 5, Seiten: 1453-1463 Artikelnummer: , Supplement: ,
Verlag American Diabetes Association
Verlagsort Alexandria, VA.
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Obesity (IDO)
Institute of Experimental Genetics (IEG)
Institute of Diabetes and Regeneration Research (IDR)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502200-001
G-500690-001
G-502390-001
PubMed ID 23305646
DOI 10.2337/db12-1116
WOS ID WOS:000318128700024
Scopus ID 84876542381
Erfassungsdatum 2013-01-28
[➜Korrektur melden]